The Munich-based WACKER Group is restructuring its sales network for biotech products in Asia to enhance efficiency and generate cross-regional synergies. As of October 2012, DKSH will be responsible for the distribution of cyclodextrins, cystine and cysteine in Southeast Asia, India and South Korea. WACKER produces these products for food and personal care applications.
As part of WACKER’s realignment of its sales structures in Asia, the company will entrust the DKSH Group with marketing and distribution of WACKER biotech products in the regions of Southeast Asia, India—including Bangladesh and Sri Lanka—and South Korea as of October 2012. The product portfolio comprises biotech cyclodextrins, as well as vegetarian-grade—i.e., fermentation-generated—cystine and cysteine. These WACKER products are primarily used in food and beverages, as well as in personal care and household products.
“The partnership with DKSH will significantly strengthen WACKER’s position in Southeast Asia, a region in which we see growing demand, particularly for our biotech products and solutions,” says Heiko Zipp, director of the Nutrition business team at WACKER BIOSOLUTIONS, WACKER’s biotech and life-sciences division.